New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.Indian pharma is standing at a defining moment. In the past 25 years, the industry has grown from $3 billion to $60 billion. The next 25 years will be shaped by innovation, quality, and access.“The year 2025…
Trending
- Why Vitamin D Deficiency Is So Common in India (Even With All That Sunshine)
- The Last Salute Movie Review 2026: An Unmissable Tribute That Soars With Raw MiG-21 Stories
- Hi Movie Review 2026: Kavin-Nayanthara’s Delightful Rom-Com Is a Refreshing Watch
- Once More (2026) Movie Review: Arjun Das and Aditi Shankar’s Heartfelt Tamil Romance Is A Beautiful Second-Chance Love Story
- Babita Singh Reporting Review 2026: A Powerful, Unforgettable Journey Into Courage and Truth
- Toxic: A Fairy Tale For Grown-Ups 2026 Movie Review— Yash Delivers A Stunning Gangster Spectacle
- Bindi, Tilak, or Sindoor: Here’s What That Dot on the Forehead Actually Means
- Bethlehem Kudumba Unit Movie Review 2026: A Heartwarming Onam Blockbuster That Wins Hearts